Illumigene C. Difficile, and Illumipro-10
C. Difficile Nucleic Acid Amplification Test Assay. 510(k) K110012, from Meridian Bioscience, Inc. (Cincinnati, OH). Product code OMN, class 1.
As of Nov 21, 2026, K110012 is an FDA 510(k) held by Meridian Bioscience, Inc., substantially equivalent on Feb 24, 2011 after 52 days, with 2 recalls tied to it in FDA's recall database.
- Review time: 52 days
- Recalls: 2
- Cited as a predicate by: 1 device
The illumigene C. difficile DNA amplification assay, performed on the illumipro-10, is a qualitative in vitro diagnostic test for the direct detection of toxigenic C. difficile in human stool specimens from pediatric and adult patients suspected of having Clostridium difficile-associated disease (CDAD). The illumigene C.
- Illumigene C. Difficile, Illumipro-10 and Illumigene C. Difficile External Control Kit, Models 280050, 610172, 279920K100818 · Meridian Bioscience, Inc. · Jul 9, 2010
- Simplexa C. Difficile Universal DirectK113433 · Focus Diagnostics, Inc. · Apr 4, 2012
| Oct 7, 2025 | Z-0568-2026The cap on the reaction buffer tube may be missing the black rubber gasket resulting in the potential for leakage and reduced buffer volume. | Open |
| Apr 22, 2014 | Z-1941-2014Illumipro-10 instruments may have Block B chambers operating at an incorrect temperature as a result of incorrect temperature calibration. | Terminated |
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Jan 3, 2011
- Review panel
- Microbiology
- Regulation
- 21 CFR 866.2660
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files